New patterns of cutaneous drug eruptions

Area of Science:

• Dermatology
• Pharmacology
• Clinical Medicine

Background:

• Cutaneous adverse drug reactions (cADRs) impose substantial clinical, financial, and psychological burdens.
• The increasing rate of drug discovery necessitates vigilance for drug-induced dermatitis.
• Diverse clinical manifestations of cADRs can mimic other dermatological conditions.

Purpose of the Study:

• To provide an updated overview of various cutaneous adverse drug reactions.
• To highlight the importance of considering drug reactions in dermatitis diagnoses.
• To review specific challenges posed by immunomodulatory drugs in oncology.

Main Methods:

• Review of current literature on cutaneous adverse drug reactions.
• Analysis of clinical presentations in inpatient and outpatient settings.
• Separate consideration of immunomodulatory drug reactions in oncology.

Main Results:

• Drug reactions present with a wide spectrum of clinical morphologies.
• Oncology immunomodulatory drugs exhibit complex and varied cutaneous side effects.
• Early recognition of cADRs is vital for patient management.

Conclusions:

• Cutaneous adverse drug reactions are a significant concern in healthcare.
• Dermatitis necessitates consideration of potential drug etiologies.
• Special attention is required for immunomodulatory agents in cancer therapy.